Retension Pharmaceuticals, Inc. (RTSN)

NASDAQ: RTSN · Real-Time Price · USD

15.50

+0.50 (3.33%)

At close: Oct 22, 2026, 4:00 PM EDT

16.38

+0.88 (5.68%)

After-hours: Oct 22, 2026, 7:50 PM EDT

Retension Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Oct '26 Oct 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Market Capitalization	129	-	-	-
Market Cap Growth	-	-	-	-
Enterprise Value	116	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Oct '26 Oct 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Debt / Equity Ratio	-1.02	-0.92	-1.01	-1.03
Quick Ratio	4.69	20.72	29.55	36.89
Current Ratio	5.61	23.51	30.22	36.89
Return on Equity (ROE)	-	-44.02%	-26.81%	-
Return on Assets (ROA)	-	-28.85%	-19.41%	-
Return on Capital Employed (ROCE)	-112.10%	-33.50%	-28.20%	-4.40%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Oct '26 Oct 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Buyback Yield / Dilution	-0.11%	-	0.00%	-

SEC Filings: 10-K · 10-Q